Vitamin D and Vitamin K in Neuro-Oncology and Brain Metabolism: Emerging Roles in Gliomas, Neurodegeneration, and Metabolic Dysregulation
Cells · 13.11.2026 · 15 (22) · 2077
DOI: 10.3390/cells15222077 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 13.11.2026. Verfasst von Julia Gałęziewska und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lodz, Polish Society of Metabolic Disorders.
Abstract (Originalsprache)
Recent advances in micronutrient biology have highlighted the pleiotropic roles of vitamins D and K in central nervous system (CNS) health and disease. Beyond their classical functions in calcium homeostasis, both vitamins exhibit regulatory effects on inflammation, oxidative stress, mitochondrial function, and gene expression, positioning them as potential modulators in neuro-oncology and neurodegeneration. In gliomas, vitamin D has been shown to influence tumour cell proliferation, differentiation, and apoptosis through vitamin D receptor (VDR)-mediated signalling, while vitamin K—particularly menaquinone—may influence glioma biology through vitamin K-dependent proteins, sphingolipid metabolism, and ferroptosis-related pathways. In neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases, deficiencies in vitamins D and K have been associated with increased neuroinflammation, impaired neuronal survival, and dysregulated protein aggregation. Emerging evidence also suggests that these vitamins play a role in brain metabolic homeostasis, particularly in glucose utilization, insulin signalling, and lipid metabolism. This is especially relevant in conditions such as brain insulin resistance and neurodegeneration linked to metabolic syndrome, where disturbances in mitochondrial function and energy metabolism may also contribute to disease progression. This review synthesizes current findings on the shared and independent roles of vitamins D and K in glioma biology, neurodegenerative processes, and brain-related metabolic disorders. It further explores their therapeutic potential as adjunctive strategies in precision medicine, while identifying key gaps for future translational research. However, current evidence remains insufficient to establish either vitamin as a disease-modifying therapy.
Förderung
- Medical University of Lodz
- Polish Society of Metabolic Disorders
Zitieren
APA
Gałęziewska, J., Kruczkowska, W., Perlikowska, R., Gromek, P., Kołat, D., Kałuzińska-Kołat, Ż., Śliwińska, A., & Płuciennik, E. (2026). Vitamin D and Vitamin K in Neuro-Oncology and Brain Metabolism: Emerging Roles in Gliomas, Neurodegeneration, and Metabolic Dysregulation. Cells, 15(22), 2077. https://doi.org/10.3390/cells15222077
Vancouver
Gałęziewska J, Kruczkowska W, Perlikowska R, Gromek P, Kołat D, Kałuzińska-Kołat Ż, et al. Vitamin D and Vitamin K in Neuro-Oncology and Brain Metabolism: Emerging Roles in Gliomas, Neurodegeneration, and Metabolic Dysregulation. Cells. 2026;15(22):2077. doi:10.3390/cells15222077
BibTeX
@article{Gaziewska2026,
author = {Gałęziewska, Julia and Kruczkowska, Weronika and Perlikowska, Renata and Gromek, Piotr and Kołat, Damian and Kałuzińska-Kołat, Żaneta and Śliwińska, Agnieszka and Płuciennik, Elżbieta},
title = {Vitamin D and Vitamin K in Neuro-Oncology and Brain Metabolism: Emerging Roles in Gliomas, Neurodegeneration, and Metabolic Dysregulation},
journal = {Cells},
year = {2026},
volume = {15},
number = {22},
pages = {2077},
doi = {10.3390/cells15222077}
}
EUVIMED